Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
Factors affecting outcomes after nephrectomy for metastatic kidney cancer
Nephrectomy is surgery to remove all or part of a [...]
Patients with metastatic kidney cancer on immunotherapy may benefit from nephrectomy
Surgery to remove the kidney and tumour (nephrectomy) has an [...]
Belzutifan significantly delays progression of advanced kidney cancer after other treatments have failed
Kidney cancers often have mutations in a gene called the von Hippel-Lindau [...]
Adjuvant therapy for kidney cancer
Adjuvant therapy aims to reduce the risk of the cancer [...]
Real-world survival outcomes of metastatic papillary and clear cell kidney cancer
In this study, real world data is used to compare [...]
Sequencing of treatments for advanced/metastatic kidney cancer
During the American Society of Clinical Oncology Annual Meeting earlier [...]
Treatment of local recurrence of kidney cancer after nephrectomy
Kidney cancer can come back after surgery to remove the [...]
Stereotactic radiotherapy with immunotherapy or targeted therapy for metastatic kidney cancer
This study looked at the safety and effectiveness of targeted [...]
Pegilodecakin alone or in combination for heavily pre-treated advanced kidney cancer patients
This study looked at the use of pegilodecakin alone or [...]
